Nanobiotix Files April 2025 6-K Report

Ticker: NBTX · Form: 6-K · Filed: Apr 2, 2025 · CIK: 1760854

Sentiment: neutral

Topics: reporting, foreign-private-issuer, sec-filing

TL;DR

Nanobiotix filed its April 6-K, standard procedure for foreign issuers.

AI Summary

Nanobiotix S.A. filed a Form 6-K on April 2, 2025, to report its activities for the month of April 2025. The company, a foreign private issuer, is based in Paris, France, and operates in the pharmaceutical preparations sector. This filing is made under the Securities Exchange Act of 1934 and indicates that Nanobiotix files annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for investors and stakeholders regarding Nanobiotix's ongoing compliance and reporting as a publicly traded foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial results or material events.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

What is Nanobiotix S.A.'s SEC file number?

Nanobiotix S.A.'s SEC file number is 001-39777.

Does Nanobiotix S.A. file annual reports under Form 20-F?

Yes, the filing indicates by check mark that Nanobiotix S.A. files or will file annual reports under cover of Form 20-F.

Where is Nanobiotix S.A. located?

Nanobiotix S.A.'s principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.

What is the SIC code for Nanobiotix S.A.?

The Standard Industrial Classification (SIC) code for Nanobiotix S.A. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 2, 2025 regarding Nanobiotix S.A. (NBTX).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing